The Company of Pharmaceutical Industries of Tunisia (SIPHAT) has achieved a turnover of 6.4 million dinars during the first six months of the year to 8.3 million for the same period last year, a decline of 23%.
The first half of the year saw a sharp decline in sales of paramedical products of hydroalcoholic solutions and gel 83% (-3 million dinars).
The export turnover achieved in H1 2021 is about 655 thousand dinars, up 139% compared to the same period last year.
As for the value of production, it went from 8.2 million dinars during the first half of the year 2020 to 6.2 million during the first half of the year 2021, a decline of 24%.
In addition, the company’s overall debt increased from 55.8 million dinars on December 31, 2020 to 61 million on June 30, 2021, posting a rise of 9%.
